{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:48Z","timestamp":1791843228886,"version":"4.3.4"},"reference-count":41,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Severe osteodystrophy is common in patients with liver dysfunction. Markers of bone metabolism may help in early diagnosis of osteodystrophy and in understanding underlying pathophysiological mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To elucidate changes in bone metabolism associated with cirrhosis and to determine the route of elimination for the markers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Case\u2013control study at a public university hospital. Fifty-nine patients with cirrhosis (47 alcoholic and 12 nonalcoholic cirrhosis) and 20 controls were included. Participants underwent catheterization of the femoral artery, and the hepatic, renal, and femoral veins with collection of blood from all 4 sites. Regional arteriovenous differences in concentrations of bone metabolism markers were determined: procollagen of type I collagen propeptide (PINP), C-terminal cross-linking telopeptide of type I collagen (CTX), osteocalcin, tartrate-resistant acid phosphatase isoform 5b (TRAcP5b), osteoprotegerin (OPG), and sclerostin and correlated with degree of disease (Child\u2013Pugh classification).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PINP concentration was higher (median: 87.9 \u00b5g\/L) in patients with cirrhosis than in controls (52.6 \u00b5g\/L) (P = .001), while hepatic extraction was lower (4.3% vs 14.5%) (P &amp;lt; .001). Both CTX and TRAcP5b were higher in patients with cirrhosis (340 ng\/L and 3.20 U\/L) than in controls (215 ng\/L and 1.60 U\/L) (P &amp;lt; .001 and P &amp;lt; .0001). Hepatic sclerostin extraction was lower in patients with cirrhosis (14.6%) than in controls (28.7%) (P &amp;lt; .0001). In both groups OPG showed a hepatic release rate (production) of 6%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with cirrhosis have increased bone resorption, but unaltered bone formation. Sclerostin is eliminated through the liver while OPG is produced in the liver. Bone markers may prove useful in evaluating bone turnover in patients with cirrhosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab788","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T17:52:28Z","timestamp":1635702748000},"page":"e980-e995","source":"Crossref","is-referenced-by-count":10,"title":["Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of Osteoprotegerin"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-5210","authenticated-orcid":false,"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Seberg","family":"Diemar","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte Lund","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kimer","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Gastro Unit, Medical Division, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Vagner","family":"Danielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"issue":"1","key":"2022021713272819200_CIT0001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology."},{"issue":"5","key":"2022021713272819200_CIT0002","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/liv.13730","article-title":"Osteoporosis in chronic liver disease","volume":"38","author":"Gua\u00f1abens","year":"2018","journal-title":"Liver Int."},{"issue":"3","key":"2022021713272819200_CIT0003","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","author":"Par\u00e9s","year":"2006","journal-title":"J Hepatol."},{"issue":"4","key":"2022021713272819200_CIT0004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF03346365","article-title":"Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol","volume":"31","author":"Santori","year":"2008","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2022021713272819200_CIT0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1359\/jbmr.2001.16.2.270","article-title":"The dose-response effects of ethanol on the human fetal osteoblastic cell line","volume":"16","author":"Maran","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2022021713272819200_CIT0006","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","article-title":"Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation","volume":"60","author":"Monegal","year":"1997","journal-title":"Calcif Tissue Int."},{"issue":"9","key":"2022021713272819200_CIT0007","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/jbmr.2845","article-title":"Sclerostin expression in bile ducts of patients with chronic cholestasis may influence the bone disease in primary biliary cirrhosis","volume":"31","author":"Gua\u00f1abens","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2022021713272819200_CIT0008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol."},{"issue":"4","key":"2022021713272819200_CIT0009","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Gua\u00f1abens","year":"2005","journal-title":"J Hepatol."},{"issue":"11","key":"2022021713272819200_CIT0010","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s10620-011-1722-y","article-title":"Hepatic osteodystrophy is common in patients with noncholestatic liver disease","volume":"56","author":"Choudhary","year":"2011","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2022021713272819200_CIT0011","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4103\/1319-2442.118078","article-title":"Effect of chronic hepatitis C virus infection on bone mineral density in pediatric renal transplant recipients","volume":"24","author":"El-Husseini","year":"2013","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"11","key":"2022021713272819200_CIT0012","doi-asserted-by":"crossref","first-page":"e81652","DOI":"10.1371\/journal.pone.0081652","article-title":"Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C","volume":"8","author":"Orsini","year":"2013","journal-title":"PLoS One."},{"issue":"2","key":"2022021713272819200_CIT0013","first-page":"82","article-title":"Hepatic osteodystrophy","volume":"31","author":"Goel","year":"2010","journal-title":"Trop Gastroenterol."},{"issue":"2","key":"2022021713272819200_CIT0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int."},{"issue":"7","key":"2022021713272819200_CIT0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat Rev Rheumatol."},{"issue":"10","key":"2022021713272819200_CIT0016","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1515\/cclm-2019-0174","article-title":"A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism","volume":"57","author":"Cavalier","year":"2019","journal-title":"Clin Chem Lab Med."},{"issue":"4","key":"2022021713272819200_CIT0017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2006.01036.x","article-title":"An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease","volume":"102","author":"Koivisto","year":"2007","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2022021713272819200_CIT0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","article-title":"Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model","volume":"82","author":"Rissanen","year":"2008","journal-title":"Calcif Tissue Int."},{"issue":"43","key":"2022021713272819200_CIT0019","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M706078200","article-title":"Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways","volume":"282","author":"Vitovski","year":"2007","journal-title":"J Biol Chem."},{"key":"2022021713272819200_CIT0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2840-10-67","article-title":"Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men","volume":"10","author":"Chen","year":"2011","journal-title":"Cardiovasc Diabetol."},{"issue":"8","key":"2022021713272819200_CIT0021","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0003319718822625","article-title":"The emerging role of bone markers in diagnosis and risk stratification of patients with coronary artery disease","volume":"70","author":"Kosmopoulos","year":"2019","journal-title":"Angiology."},{"issue":"5","key":"2022021713272819200_CIT0022","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.diabet.2016.02.004","article-title":"Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults","volume":"42","author":"Monseu","year":"2016","journal-title":"Diabetes Metab."},{"issue":"19","key":"2022021713272819200_CIT0023","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3748\/wjg.v24.i19.2073","article-title":"Role of osteoprotegerin\/receptor activator of nuclear factor kappa B\/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease","volume":"24","author":"Pacifico","year":"2018","journal-title":"World J Gastroenterol."},{"issue":"1-2","key":"2022021713272819200_CIT0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00508-019-01595-8","article-title":"Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis","volume":"132","author":"Wakolbinger","year":"2020","journal-title":"Wien Klin Wochenschr."},{"issue":"4","key":"2022021713272819200_CIT0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0026-0495(87)90210-1","article-title":"Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation","volume":"36","author":"Gluud","year":"1987","journal-title":"Metabolism."},{"issue":"8476","key":"2022021713272819200_CIT0026","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet."},{"issue":"7","key":"2022021713272819200_CIT0027","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00198-017-4026-z","article-title":"Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population","volume":"28","author":"J\u00f8rgensen","year":"2017","journal-title":"Osteoporos Int."},{"issue":"8","key":"2022021713272819200_CIT0028","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00365519950185120","article-title":"Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis","volume":"59","author":"Schytte","year":"1999","journal-title":"Scand J Clin Lab Invest."},{"issue":"1-2","key":"2022021713272819200_CIT0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365513.2017.1420217","article-title":"Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases","volume":"78","author":"Gudowska-Sawczuk","year":"2018","journal-title":"Scand J Clin Lab Invest."},{"issue":"3","key":"2022021713272819200_CIT0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/gut.44.3.417","article-title":"Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism","volume":"44","author":"M\u00f8ller","year":"1999","journal-title":"Gut."},{"issue":"1","key":"2022021713272819200_CIT0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00198-014-2849-4","article-title":"Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis","volume":"26","author":"Culafi\u0107","year":"2015","journal-title":"Osteoporos Int."},{"issue":"2","key":"2022021713272819200_CIT0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2022021713272819200_CIT0033","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/NDT.S153360","article-title":"A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients","volume":"14","author":"Horai","year":"2018","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"19","key":"2022021713272819200_CIT0034","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2106\/JBJS.M.01096","article-title":"A review of osteocyte function and the emerging importance of sclerostin","volume":"96","author":"Compton","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"2022021713272819200_CIT0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022021713272819200_CIT0036","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00774-013-0524-z","article-title":"Effect of liver dysfunction on circulating sclerostin","volume":"32","author":"Rhee","year":"2014","journal-title":"J Bone Miner Metab."},{"issue":"12","key":"2022021713272819200_CIT0037","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1210\/jc.2009-0835","article-title":"Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis","volume":"94","author":"Gonz\u00e1lez-Calvin","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022021713272819200_CIT0038","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3892\/etm.2016.3754","article-title":"Concentrations of fetuin-A, osteoprotegerin and \u03b1-Klotho in patients with alcoholic liver cirrhosis","volume":"12","author":"Prystupa","year":"2016","journal-title":"Exp Ther Med."},{"issue":"3","key":"2022021713272819200_CIT0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/alcalc\/agl004","article-title":"Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease","volume":"41","author":"Garc\u00eda-Valdecasas-Campelo","year":"2006","journal-title":"Alcohol Alcohol."},{"issue":"5","key":"2022021713272819200_CIT0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/pharmaceutics12050471","article-title":"Osteoprotegerin is more than a possible serum marker in liver fibrosis: a study into its function in human and murine liver","volume":"12","author":"Adhyatmika","year":"2020","journal-title":"Pharmaceutics."},{"issue":"3","key":"2022021713272819200_CIT0041","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00198-020-05310-6","article-title":"Harmonization of commercial assays for PINP; the way forward","volume":"31","author":"Vasikaran","year":"2020","journal-title":"Osteoporos Int."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab788\/41428527\/dgab788.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/3\/e980\/42544470\/dgab788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/3\/e980\/42544470\/dgab788.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T13:29:02Z","timestamp":1645104542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/3\/e980\/6414605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,10,30]]},"published-print":{"date-parts":[[2022,2,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab788","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,10,30]]}}}